Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

-Anasuya Ray Researcher Activity Profile

Research Author Detailed Information 

profile photo of Anasuya RayAnasuya ray researcher

Anasuya Ray Publication Rate By Year

Anasuya Ray has published 1 paper(s) in 1965, 1 paper(s) in 2002, 2 paper(s) in 2006, 30 paper(s) in 2007, 14 paper(s) in 2008, for a total of 48 research publications in total.

Anasuya A Ray Author Information

LAST NAME: ray

FIRST NAME: Anasuya

INITIALS: a

AFFILIATION:

Papers

Anasuya Ray's Publication Record

  1. Mechanism of action of the microtubule-targeted antimitotic depsipeptide tasidotin (formerly ILX651) and its major metabolite tasidotin C-carboxylate. Year Published: 2007
  2. Department of Molecular, Cellular, and Developmental Biology and the Neuroscience Research Institute, University of California-Santa Barbara, Santa Barbara, CA 93106, USA.
  3. Soluble transferrin receptor as an indicator of iron deficiency in HIV-infected infants. Year Published: 2007
  4. Johns Hopkins School of Medicine, Baltimore, Maryland, USA.
  5. Localization of the pannexin1 protein at postsynaptic sites in the cerebral cortex and hippocampus. Year Published: 2007
  6. Department of Neuroanatomy and Molecular Brain Research, Ruhr University Bochum, Universitystreet 150, D-44780 Bochum, Germany.
  7. Cytoskeletal scaffolds regulate riboflavin endocytosis and recycling in placental trophoblasts. Year Published: 2006
  8. Department of Pharmaceutical Sciences, University of Maryland, Baltimore, MD 21201, USA.
  9. Effects of PKC412, nilotinib, and imatinib against GIST-associated PDGFRA mutants with differential imatinib sensitivity. Year Published: 2006
  10. Department of Medical Oncology, Dana Farber Cancer Institute, Boston, Massachusetts 02115, USA. Ellen_weisberg@dfci.harvard.edu
  11. RBx 7,796: A novel inhibitor of 5-lipoxygenase. Year Published: 2007
  12. Department of Pharmacology, New Drug Discovery Research, Ranbaxy Research Laboratories, Plot No-20, Sector-18, Udyog Vihar, Gurgaon, Haryana 122015, India.
  13. Vascular endothelial growth factor expression in arthritic joint is regulated by SAF-1 transcription factor. Year Published: 2007
  14. Department of Veterinary Pathobiology, University of Missouri, Columbia, MO 65211, USA.
  15. Mechanisms of odor receptor gene choice in Drosophila. Year Published: 2007
  16. Department of Molecular, Cellular, and Developmental Biology, Yale University, New Haven, CT 06520, USA.
  17. Potentiation of antileukemic therapies by Smac mimetic, LBW242: effects on mutant FLT3-expressing cells. Year Published: 2007
  18. Department of Adult Oncology, Dana-Farber Cancer Institute, 44 Binney Street, Boston, MA 02115, USA.
  19. Deficient SOCS3 expression in CD4+CD25+FoxP3+ regulatory T cells and SOCS3-mediated suppression of Treg function. Year Published: 2007
  20. Department of Medicine, Pulmonary, Allergy and Critical Care Division, University of Pittsburgh School of Medicine, Pittsburgh, PA 15213, USA.
  21. Dynamin 2 regulates riboflavin endocytosis in human placental trophoblasts. Year Published: 2007
  22. Department of Pharmaceutical Sciences, School of Pharmacy, University of Maryland, Baltimore, MD 21201, USA.
  23. Comparative in vivo effects of parathion on striatal acetylcholine accumulation in adult and aged rats. Year Published: 2007
  24. Department of Physiological Sciences, Center for Veterinary Health Sciences, Oklahoma State University, Stillwater, OK 74078, United States.
  25. Modulation of stress-induced neurobehavioral changes and brain oxidative injury by nitric oxide (NO) mimetics in rats. Year Published: 2007
  26. Department of Pharmacology, Vallabhbhai Patel Chest Institute, University of Delhi, Delhi 110007, India.
  27. Comparative in vivo uroselectivity profiles of anticholinergics, tested in a novel anesthetized rabbit model. Year Published: 2007
  28. Department of Pharmacology, Ranbaxy Research Laboratories, Plot-20, Sector-18, Gurgaon 122 015, India. naruganahalli.krishna@ranbaxy.com
  29. Transposon excision from an atypical site: a mechanism of evolution of novel transposable elements. Year Published: 2007
  30. Department of Biology, University of Rochester, Rochester, New York, United States of America.
  31. Effects of prolonged stimulation at the electrode-retina interface. Year Published: 2007
  32. Dept. of Biomed. Eng., Univ. of Southern California, Los Angeles, CA.
  33. Neo-adjuvant chemotherapy with cisplatin and short infusional 5-FU in advanced head and neck malignancies. Year Published: 2007
  34. Department of Radiotherapy, N.R.S. Medical College and Hospital, 138, A.J.C. Bose Road, Kolkata, India. amitabh.r@rediffmail.com
  35. The impact of cerebral source area and synchrony on recording scalp electroencephalography ictal patterns. Year Published: 2007
  36. Adult Epilepsy Service, Department of Neurology, The University of Chicago, Chicago, Illinois, U.S.A.
  37. Differential Modification of p27Kip1 Controls Its Cyclin D-cdk4 Inhibitory Activity. Year Published: 2007
  38. Department of Pediatrics, SUNY Downstate Medical Center, 450 Clarkson Ave., Box 49, Brooklyn, NY 11203. stacy.blain@downstate.edu.
  39. Modulation of stress-induced neurobehavioral changes and brain oxidative injury by nitric oxide (NO) mimetics in rats. Year Published: 2007
  40. Department of Pharmacology, Vallabhbhai Patel Chest Institute, University of Delhi, Delhi 110007, India.
  41. The impact of cerebral source area and synchrony on recording scalp electroencephalography ictal patterns. Year Published: 2007
  42. Adult Epilepsy Service, Department of Neurology, The University of Chicago, 5841 South Maryland Avenue, Chicago, IL 60637, U.S.A. jtao@neurology.bsd.uchicago.edu
  43. Cross-talk among structural domains of human DBP upon binding 25-hydroxyvitamin D. Year Published: 2007
  44. Bioorganic Chemistry & Structural Biology, Department of Medicine, Boston University School of Medicine, 85 East Newton Street, Boston, MA 02118, USA.
  45. Differential modification of p27Kip1 controls its cyclin D-cdk4 inhibitory activity. Year Published: 2007
  46. Department of Pediatrics, SUNY Downstate Medical Center, 450 Clarkson Ave., Box 49, Brooklyn, NY 11203, USA. stacy.blain@downstate.edu
  47. Neo-adjuvant chemotherapy with cisplatin and short infusional 5-FU in advanced head and neck malignancies. Year Published: 2007
  48. Department of Radiotherapy, N.R.S. Medical College and Hospital, 138, A.J.C. Bose Road, Kolkata, India. amitabh.r@rediffmail.com
  49. The impact of cerebral source area and synchrony on recording scalp electroencephalography ictal patterns. Year Published: 2007
  50. Adult Epilepsy Service, Department of Neurology, The University of Chicago, 5841 South Maryland Avenue, Chicago, IL 60637, U.S.A. jtao@neurology.bsd.uchicago.edu
  51. Cross-talk among structural domains of human DBP upon binding 25-hydroxyvitamin D. Year Published: 2007
  52. Bioorganic Chemistry & Structural Biology, Department of Medicine, Boston University School of Medicine, 85 East Newton Street, Boston, MA 02118, USA.
  53. Differential modification of p27Kip1 controls its cyclin D-cdk4 inhibitory activity. Year Published: 2007
  54. Department of Pediatrics, SUNY Downstate Medical Center, 450 Clarkson Ave., Box 49, Brooklyn, NY 11203, USA. stacy.blain@downstate.edu
  55. Comparative in vivo uroselectivity profiles of anticholinergics, tested in a novel anesthetized rabbit model. Year Published: 2007
  56. Department of Pharmacology, Ranbaxy Research Laboratories, Plot-20, Sector-18, Gurgaon 122 015, India. naruganahalli.krishna@ranbaxy.com
  57. Neo-adjuvant chemotherapy with cisplatin and short infusional 5-FU in advanced head and neck malignancies. Year Published: 2007
  58. Department of Radiotherapy, N.R.S. Medical College and Hospital, 138, A.J.C. Bose Road, Kolkata, India. amitabh.r@rediffmail.com
  59. Trehalose glass-facilitated thermal reduction of metmyoglobin and methemoglobin. Year Published: 2002
  60. Department of Physiology and Biophysics, Albert Einstein College of Medicine, Bronx, New York 10461, USA.
  61. Genetic polymorphisms in CYP17, CYP3A4, CYP19A1, SRD5A2, IGF-1, and IGFBP-3 and prostate cancer risk in African-American men: The Flint Men's Health Study. Year Published: 2008
  62. Department of Urology, University of Michigan Medical School, Ann Arbor, Michigan.
  63. Neo-adjuvant chemotherapy with cisplatin and short infusional 5-FU in advanced head and neck malignancies. Year Published: 2007
  64. Department of Radiotherapy, N.R.S. Medical College and Hospital, 138, A.J.C. Bose Road, Kolkata, India. amitabh.r@rediffmail.com
  65. MOLECULAR COMPLEXES OF FLAVINS AND PHENOLS. II. ELECTRICAL AND MAGNETIC PROPERTIES OF CRYSTALLINE SOLIDS. Year Published: 1965
  66. Effects of adiponectin on breast cancer cell growth and signaling. Year Published: 2008
  67. 1Hormel Institute, University of Minnesota, 801 16th Avenue NE, Austin, MN 55912, USA.
  68. Expression of serum amyloid A transcripts in human bone tissues, differentiated osteoblast-like stem cells and human osteosarcoma cell lines. Year Published: 2008
  69. Institute of Molecular Biology and Biochemistry, Center of Molecular Medicine, Medical University of Graz, Center of Molecular Medicine, Graz, Austria.
  70. Mechanisms of odor receptor gene choice in Drosophila. Year Published: 2007
  71. Department of Molecular, Cellular, and Developmental Biology, Yale University, New Haven, CT 06520, USA.
  72. Bioaccumulation of heavy metals by green algae. Year Published: 2008
  73. Department of Chemistry, Sardar Patel University, V.V. Nagar, 388 120, Gujarat, India.
  74. Effects of prolonged stimulation at the electrode-retina interface. Year Published: 2007
  75. Department of Biomedical Engineering, University of Southern California, Los Angeles, CA, USA.
  76. Synthesis, anti-HIV activity, and resistance profiles of ribose modified nucleoside phosphonates. Year Published: 2008
  77. Gilead Sciences, Inc., 333 Lakeside Drive, Foster City, CA 94404, USA. rmackman@gilead.com
  78. Cysteine cathepsin S as an immunomodulatory target: present and future trends. Year Published: 2008
  79. Ranbaxy Research Laboratories, Department of Pharmacology, New Drug Discovery Research, Plot 20, Sector 18, Udyog Vihar Industrial Area, Gurgaon-1220015, Haryana, India. suman.gupta@ranbaxy.com
  80. Expression of serum amyloid A transcripts in human bone tissues, differentiated osteoblast-like stem cells and human osteosarcoma cell lines. Year Published: 2008
  81. Institute of Molecular Biology and Biochemistry, Center of Molecular Medicine, Medical University of Graz, Center of Molecular Medicine, Graz, Austria.
  82. Potentiation of antileukemic therapies by the dual PI3K/PDK-1 inhibitor, BAG956: effects on BCR-ABL- and mutant FLT3-expressing cells. Year Published: 2008
  83. Effects of adiponectin on breast cancer cell growth and signaling. Year Published: 2008
  84. Hormel Institute, University of Minnesota, 801 16th Avenue NE, Austin, MN 55912, USA.
  85. Pharmacodynamic and pharmacokinetic characterisation of RBx 7796: a novel 5-lipoxygenase inhibitor. Year Published: 2008
  86. Department of Pharmacology, New Drug Discovery Research, Ranbaxy Research Laboratories, Plot No-20, Sector-18, Udyog Vihar, Gurgaon, Haryana, 122015, India.
  87. Genetic polymorphisms in CYP17, CYP3A4, CYP19A1, SRD5A2, IGF-1, and IGFBP-3 and prostate cancer risk in African-American men: the Flint Men's Health Study. Year Published: 2008
  88. Department of Urology, University of Michigan Medical School, Ann Arbor, Michigan, USA. asarma@umich.edu
  89. Nurse and patient communication profiles in a home-based telehealth intervention for heart failure management. Year Published: 2008
  90. Research Service, Harry S. Truman Memorial Veterans Hospital, 800 Hospital Drive, Columbia, MO 65201, United States; Sinclair School of Nursing, University of Missouri, Columbia, MO, United States.
  91. Bioaccumulation of heavy metals by green algae. Year Published: 2008
  92. Department of Chemistry, Sardar Patel University, V.V. Nagar, 388 120 Gujarat, India.
  93. Potentiation of antileukemic therapies by the dual PI3K/PDK-1 inhibitor, BAG956: effects on BCR-ABL- and mutant FLT3-expressing cells. Year Published: 2008
  94. Department of Medical Oncology/Hematologic Neoplasia, Dana-Farber Cancer Institute, Boston, MA 02115, USA.
 

Molecular Station USER Menu

Welcome to Molecular Station!

You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

Already registered? Login now below.

User Name:

Password:

Already registered and Forgot your password? Click below to recover it.

Recover Lost Password

Join now - it's fast and free!

Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

Research Terms of Usage and Disclaimer
Home
Features

Protocols

DNA Forum

Science Forum

DNA Forum
Biology Forum

Science News


[CaRP] XML error: Invalid document end at line 2

For more click here:Science News